Caris Downgrades Endo Pharmaceuticals (ENDP) to Average, Raises Price Target
Tweet Send to a Friend
Caris & Co. downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) to an Average rating from its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE